Medical and Pharma Research

Medical literature review workflow: From Search Results to Cited Synthesis

A practical medical literature review workflow for turning database results into a traceable, cited synthesis. Separate discovery, screening, extraction, appraisal, and writing while keeping systematic-review boundaries clear.

People in the office

Updated October 16, 2026.

What a medical literature review workflow should produce

A medical literature review workflow should produce a traceable chain from a focused clinical question to a documented search, screened studies, structured evidence extraction, critical comparison, and a cited synthesis. The output is not “a folder of PDFs.” It is a set of claims that can be checked against named sources, with the population, intervention or exposure, comparator, outcome, uncertainty, and limitations still intact.

The safest workflow separates five jobs: discovery, screening, extraction, appraisal, and writing. AI can help organize papers, compare passages, extract candidate study details, and draft from supplied sources. It should not be treated as the clinical authority. Every clinical claim, citation, population, intervention, comparator, outcome, date, and guideline statement still needs verification against the original publication.

That boundary matters because “literature review” is not one method. A narrative or clinical background review may use a structured search and transparent synthesis without claiming systematic-review status. A systematic review or scoping review carries heavier obligations: protocol decisions, reproducible searching, explicit screening, appraisal or charting decisions, and reporting standards. Columbia’s systematic review guidance defines systematic reviews around a focused question plus a comprehensive, reproducible search and analysis of the relevant literature. Columbia University Libraries

Medical literature review workflow from question to synthesis

For general writing structure, use a separate guide on how to write a literature review. The workflow below is narrower: how to handle medical evidence so the final synthesis is auditable.

A useful finished review should show:

  • What question was asked. The scope should be specific enough that another reviewer can understand why a study was included or excluded.

  • Where the evidence came from. Databases, search strings, filters, dates, and supplementary discovery methods should be recorded.

  • What was screened out and why. Especially at full-text screening, exclusion reasons should be short, consistent, and recoverable.

  • What each included source actually contributes. Not just the abstract conclusion, but the study design, population, outcomes, follow-up, limitations, and relevant source location.

  • Where studies agree, disagree, or fail to answer the question. A medical synthesis should preserve uncertainty, not sand it down.

  • Which claim rests on which source. Important claims should point back to a source passage, table, figure, page, section, or data element when the format allows it.

Start with a focused clinical question and a reproducible search record

A medical review starts to fail when the search begins before the question is stable. “Metformin and long COVID” is a topic. A review question needs concepts: population, condition, exposure or intervention, comparator, outcome, setting, timing, and eligible study designs.

The exact framework depends on the job. PICO is useful for intervention questions. PECO often fits exposure questions. SPIDER or similar frameworks can suit qualitative evidence. The framework is less important than making the concepts explicit before search results start shaping the question.

A structured search record should capture:

  • Review objective: the clinical or research question in one sentence.

  • Core concepts: population, disease or condition, intervention or exposure, comparator, outcomes, setting, and study design.

  • Databases and platforms searched: for example PubMed/MEDLINE, Embase, Cochrane Library, CINAHL, PsycINFO, trial registries, and guideline repositories when relevant.

  • Search strings: controlled vocabulary terms, keywords, synonyms, truncation, Boolean logic, proximity operators, and field tags.

  • Limits and filters: date range, language, humans or animals, age group, article type, geography, and study design filters.

  • Search date: the date each search was run.

  • Result counts: total hits before and after deduplication.

  • Duplicate handling: tool used and rule for resolving duplicates.

  • Supplementary discovery: citation chasing, related-article tools, expert recommendations, reference lists, and search engines.

Cooper and colleagues reviewed guidance on literature searching and found that searching for systematic reviews is not a single mechanical step; it involves planning, identifying sources, running searches, managing records, and reporting the process. BMC Medical Research Methodology That lesson applies even when the final product is not a systematic review: a search record makes the review defensible.

Discovery tools and search engines are useful, but they should not decide inclusion. Citation maps, related-article features, and broad web searches can surface leads. Selection decisions should still be based on predefined criteria and the full source, not a search snippet or abstract alone. For a wider view of discovery sources, see Otio’s guide to good websites for research.

A worked example: narrowing before screening

Suppose the broad objective is:

“Review medical evidence on remote monitoring for adults with heart failure.”

Before screening, turn that into a question sheet:

  • Population: adults with chronic heart failure.

  • Intervention or exposure: remote patient monitoring, telemonitoring, connected devices, app-based monitoring, home vital-sign reporting.

  • Comparator: usual care, clinic-based monitoring, or another digital monitoring strategy.

  • Outcomes: hospitalization, mortality, emergency visits, quality of life, adherence, adverse events, cost or resource use.

  • Setting: outpatient or post-discharge care.

  • Study designs: randomized trials, observational cohort studies, systematic reviews, guideline statements, or qualitative implementation studies, depending on the review purpose.

  • Initial exclusions: pediatric populations, inpatient-only monitoring, non-heart-failure populations, opinion pieces without evidence, device feasibility studies without patient outcomes if patient outcomes are the review focus.

That sheet does not assert any finding. It prevents the search from becoming a moving target.

A search log might then record that PubMed was searched on a specific date using controlled vocabulary and free-text terms for heart failure plus telemonitoring concepts, with no date limit at first. If the result set is unmanageably broad, the narrowing rule should be documented: for example, limit to adults, human studies, English-language full text, randomized trials and cohort studies, or a defined publication window if justified by the review question.

Screen studies and build an evidence set without losing context

Screening is a two-pass process: title and abstract first, full text second. Title and abstract screening removes obviously irrelevant records. Full-text screening tests the remaining papers against eligibility criteria and records a reason for each exclusion.

Virginia Tech’s systematic review guidance describes screening titles and abstracts, then full text, against the predefined scope. Virginia Tech University Libraries Rutgers’ guidance adds a practical requirement: studies excluded after full-text evaluation should have a rationale recorded, and the process should be captured in the study-selection flow. Rutgers University Libraries

Even for a narrative medical review, this discipline is useful. It keeps later writing from drifting toward whichever papers were easiest to read, most recent, or most rhetorically convenient.

Before synthesis, capture enough metadata to compare studies without repeatedly reopening every PDF:

  • Citation details: authors, title, journal, year, DOI or PMID when available.

  • Publication type: original research, review, guideline, editorial, letter, conference abstract, preprint.

  • Study design: randomized trial, cohort, case-control, cross-sectional, diagnostic accuracy study, qualitative study, economic evaluation, secondary analysis.

  • Population: inclusion criteria, exclusion criteria, disease severity, age range, sex distribution, comorbidities, baseline risk.

  • Sample: sample size, number analyzed, attrition, missing data.

  • Intervention or exposure: dose, duration, device, implementation model, diagnostic threshold, exposure definition.

  • Comparator: usual care, placebo, active comparator, unexposed group, historical control.

  • Outcomes: primary and secondary outcomes, surrogate outcomes, patient-important outcomes, follow-up duration.

  • Setting: country, health system, inpatient, outpatient, primary care, specialty clinic, trial site type.

  • Limitations: bias risks, confounding, measurement issues, short follow-up, underpowered subgroup analysis.

  • Funding and conflicts: sponsor, industry involvement, author disclosures.

  • Source locations: page, table, figure, appendix, trial registry entry, or guideline section.

An evidence matrix is the working structure, not the final answer. It helps compare like with like. It also stops a common error: treating a surrogate outcome as if it were the same as a patient-important outcome, or compressing very different study designs into one implied certainty score.

Evidence matrix for medical studies

Edge cases need explicit handling:

  • Inaccessible full text: decide whether to exclude, obtain through library access, contact authors, or retain only for background if the abstract is insufficient for extraction.

  • Retracted or corrected papers: check whether the record has an erratum, correction, expression of concern, or retraction before relying on it.

  • Duplicate cohorts: multiple papers may analyze the same patient cohort. Count the cohort once for population-level claims unless the secondary paper answers a distinct question.

  • Conference abstracts later published as articles: prefer the full peer-reviewed article when it reports the same study more completely.

  • Preprints: label them as preprints and avoid giving them the same evidentiary weight as peer-reviewed, final publications.

  • Secondary analyses: useful for subgroup or mechanism questions, but they should not be mistaken for independent trials.

  • Inconsistent terminology: map synonyms carefully. A term such as “remission,” “response,” or “disease control” may use different thresholds across studies.

This is where a permanent research workspace helps. After discovery, Otio for medical research can keep PDFs, web pages, notes, and source excerpts in one library, while the AI PDF reader lets researchers ask questions inside PDFs and preserve citation context. That does not replace screening judgment; it reduces the friction of moving between files, notes, and draft reasoning.

[[OTIO_INLINE_PROMO:%7B%22title%22%3A%22Ready%20to%20build%20a%20source-linked%20evidence%20matrix%3F%22%2C%22description%22%3A%22Add%20screened%20PDFs%20and%20web%20pages%20to%20Otio%2C%20then%20capture%20study%20details%2C%20limitations%2C%20and%20source%20locations%20in%20one%20library.%22%7D]]

Compare the evidence before asking AI to synthesize it

Do not ask AI for a synthesis until the evidence has been organized. If the input is a pile of papers, the output will often be a fluent pile of paper-level summaries. Medical readers need comparisons, not one paragraph per article.

Organize the synthesis around the thing being judged:

  • By clinical question: effectiveness, safety, diagnosis, prognosis, implementation, cost.

  • By outcome: mortality, hospitalization, symptom scores, biomarker change, adverse events, quality of life.

  • By population: disease severity, age group, comorbidity, pregnancy status, immunocompromised status, geographic setting.

  • By mechanism: pharmacologic pathway, device function, behavioral intervention component.

  • By study design: trials first, then observational evidence, then qualitative or mechanistic evidence where relevant.

For each provisional conclusion, compare more than the headline result:

  • Direction of findings: benefit, harm, no clear difference, mixed evidence.

  • Magnitude: absolute effects when available, not just relative effects.

  • Precision: confidence intervals, event counts, and whether the study was powered for the outcome.

  • Follow-up: short-term signal versus durable clinical outcome.

  • Applicability: whether the study population matches the population in the review question.

  • Risk of bias: selection, performance, detection, attrition, reporting, confounding.

  • Outcome importance: patient-important outcome versus surrogate or process measure.

  • Consistency: whether similar findings come from independent cohorts or the same research group, dataset, or trial family.

Ohio State’s systematic review guidance notes that all reviews should include qualitative synthesis, whether or not they include quantitative synthesis such as meta-analysis. Ohio State University Health Sciences Library In practical terms, that means the synthesis must explain what the evidence shows and why it should or should not be believed.

The claim-to-source workflow

Use a claim-to-source loop before drafting polished prose:

  1. Write the provisional claim. Example: “Remote monitoring may reduce heart-failure-related hospitalization in selected outpatient populations.”

  2. Attach the supporting evidence. Link the exact passage, table, figure, forest plot, or outcome row.

  3. Check the wording against the source. Did the study measure hospitalization, all-cause admission, emergency visits, or a composite endpoint?

  4. Check the population. Was it chronic heart failure, post-discharge heart failure, reduced ejection fraction, preserved ejection fraction, or a mixed group?

  5. Check certainty. Was the finding statistically precise? Was it a subgroup? Was it exploratory?

  6. Qualify the claim. If the evidence is indirect, mixed, short-term, or design-limited, say so.

This prevents citation laundering. Citation laundering happens when a synthesis keeps a real citation but silently changes what the citation supports: the population shifts, the endpoint changes, the direction of effect is overstated, or uncertainty disappears. The final sentence looks cited. The reasoning is no longer faithful.

AI is useful inside this bounded loop. One model can extract study characteristics into a draft matrix. Another can challenge unsupported inferences or list places where the wording exceeds the evidence. Otio’s multiple AI models support that kind of side-by-side checking, but the researcher remains responsible for verifying each claim against the original source.

Citation-checking tools can add another signal. For example, scite ai can help examine how papers are cited and whether later literature discusses, supports, or contrasts with a claim. That is context, not a substitute for reading the study.

Draft the cited synthesis and run a final medical evidence audit

The writing stage should not begin with a blank page. It should begin with a question sheet, search log, screened evidence set, extraction matrix, and claim-to-source notes.

A strong medical synthesis usually moves in this order:

  1. Question and scope: what the review asked, what evidence types were included, and what was outside scope.

  2. Search and selection summary: where evidence was found and how sources were selected.

  3. Main evidence by outcome or question: what the included studies show, grouped by the reader’s decision need.

  4. Disagreements and heterogeneity: where studies conflict and why that may be happening.

  5. Applicability: how well the evidence maps to the target clinical population or setting.

  6. Limitations: limits of the evidence base and limits of the review method.

  7. Uncertainty and next questions: what remains unresolved and what evidence would change the conclusion.

Place citations next to the claims they support. Avoid a long citation cluster at the end of a paragraph that contains six different claims. If one source supports the population statement and another supports the outcome estimate, cite them separately.

When possible, preserve source location. For PDFs, that may be page, table, figure, appendix, or supplement. For guidelines, it may be section or recommendation number. For trial registries, it may be the outcome field or posted results section. Location metadata is tedious during extraction and invaluable during final audit.

Before sending the review to collaborators, a supervisor, a journal, or a clinical audience, run a medical evidence audit:

  • Citation accuracy: every citation points to the source that actually supports the sentence.

  • Population match: the claim does not generalize beyond the study population.

  • Comparator match: usual care, placebo, active comparator, and historical control are not treated as interchangeable.

  • Outcome match: surrogate, composite, process, and patient-important outcomes remain distinct.

  • Direction of effect: benefit, harm, null findings, and uncertainty are not reversed or softened incorrectly.

  • Magnitude and precision: relative effects are not presented without context when absolute risk matters.

  • Duplicate studies: the same cohort or trial is not counted as independent evidence twice.

  • Corrections and retractions: key studies have been checked for updates.

  • Guideline currency: clinical guidance is not outdated relative to newer recommendations.

  • Funding and conflicts: sponsor influence and author disclosures are visible where relevant.

  • Review-design honesty: the final report does not claim to be a systematic review if the methods do not support that label.

  • AI residue: no generated citation, invented source detail, or unsupported synthesis sentence remains.

If the review is intended to be systematic, do not retrofit the label after drafting. Systematic-review methods require predefined eligibility criteria, comprehensive and reproducible searching, documented screening, data extraction, appraisal, and reporting choices. Goodfellow’s overview of medical literature searching and writing emphasizes that analyzing search results and writing the review are part of understanding the research question’s importance and meaning, not just clerical steps. PMC

For multi-source projects, Otio works best as the handoff from discovery into a durable research workspace: store source files, notes, quoted evidence, and draft reasoning together. Check Otio pricing for current access details and plan limits before building a large project.

The next action is simple: create a one-page review question sheet and a search log before opening another paper. Run the first documented search, save the resulting papers, extract source-linked notes, and only then start drafting synthesis prose.

FAQ

Q: What is the first step in a medical literature review workflow?
A: Define a focused clinical or research question and document the concepts, eligibility criteria, and intended review type before searching. This prevents an unstructured collection of papers from becoming the evidence base by accident.

Q: How is a medical literature review different from a systematic review?
A: A general or narrative literature review may use a structured search and synthesis without claiming systematic-review status. A systematic review follows a predefined, reproducible protocol for searching, screening, appraisal, and reporting, so the label should match the methods actually used.

Q: Can AI write a medical literature review?
A: AI can help organize sources, extract candidate details, compare documents, and draft from supplied evidence, but it should not be treated as the clinical authority. Researchers must verify claims, citations, study populations, outcomes, and limitations against the original sources.

Q: How do you prevent citation errors in a medical literature review?
A: Maintain a claim-to-source record, attach each important statement to the exact supporting passage or table, and audit the final draft for population, outcome, direction-of-effect, and certainty mismatches. Never rely on a generated citation or summary without checking the original paper.

[[OTIO_FOOTER_PROMO:%7B%22title%22%3A%22Bring%20your%20review%20sources%20into%20one%20workspace%22%2C%22description%22%3A%22Upload%20your%20PDFs%2C%20save%20key%20web%20pages%2C%20and%20ask%20Otio%20to%20compare%20source%20passages%20while%20you%20verify%20every%20clinical%20claim%20against%20the%20originals.%22%7D]]

Related reading